Ładuje się......
Bispecifics, trispecifics, and other novel immune treatments in myeloma
Despite recent advances in treatment, relapses in multiple myeloma (MM) are inevitable. Off-the-shelf immunotherapeutics represent a promising avenue for research, with various classes of agents under development and several demonstrating deep and durable responses in patients who have exhausted all...
Zapisane w:
| Wydane w: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Główni autorzy: | , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society of Hematology
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7727546/ https://ncbi.nlm.nih.gov/pubmed/33275733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2020000110 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|